Koufakis, Theocharis
Pavlidis, Antonis N.
Metallidis, Symeon
Kotsa, Kalliopi http://orcid.org/0000-0003-2376-740X
Article History
Received: 12 January 2021
Accepted: 22 February 2021
First Online: 9 March 2021
Conflicts of interest
: TK has received honoraria as a speaker from AstraZeneca, Boehringer Ingelheim and Novo Nordisk and has participated in sponsored studies by Eli-Lilly. KK has received honoraria for lectures/advisory boards and research support. from Astra Zeneca, Boehringer Ingelheim, Pharmaserve Lilly, Sanofi-Aventis, ELPEN, MSD, and Novo Nordisk.Other authors report no conflict of interest.
Free to read: This content has been made available to all.